NDC 68084-956

Sirolimus

Sirolimus

Sirolimus is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by American Health Packaging. The primary component is Sirolimus.

Product ID68084-956_7b953e74-8cd0-7f3d-e053-2a91aa0a0d7d
NDC68084-956
Product TypeHuman Prescription Drug
Proprietary NameSirolimus
Generic NameSirolimus
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2015-03-31
Marketing CategoryANDA / ANDA
Application NumberANDA201676
Labeler NameAmerican Health Packaging
Substance NameSIROLIMUS
Active Ingredient Strength1 mg/1
Pharm ClassesDecreased Immunologic Activity [PE],mTOR Inhibitor Immunosuppressant [EPC],mTOR Inhibitors [MoA],Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 68084-956-25

30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-956-25) > 1 TABLET, FILM COATED in 1 BLISTER PACK (68084-956-95)
Marketing Start Date2015-09-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68084-956-11 [68084095611]

Sirolimus TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA201676
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-03-31
Marketing End Date2020-04-30

NDC 68084-956-25 [68084095625]

Sirolimus TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA201676
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-09-30
Marketing End Date2020-04-30

NDC 68084-956-95 [68084095695]

Sirolimus TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA201676
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-11-10
Marketing End Date2020-04-30

NDC 68084-956-21 [68084095621]

Sirolimus TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA201676
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-03-31
Marketing End Date2015-11-10

Drug Details

Active Ingredients

IngredientStrength
SIROLIMUS.5 mg/1

OpenFDA Data

SPL SET ID:f06f88c9-462c-4bf3-aac3-2d155680df6d
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 905158
  • Pharmacological Class

    • Decreased Immunologic Activity [PE]
    • mTOR Inhibitor Immunosuppressant [EPC]
    • mTOR Inhibitors [MoA]
    • Kinase Inhibitor [EPC]
    • Protein Kinase Inhibitors [MoA]

    Medicade Reported Pricing

    68084095695 SIROLIMUS 0.5 MG TABLET

    Pricing Unit: EA | Drug Type:

    68084095625 SIROLIMUS 0.5 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Sirolimus" or generic name "Sirolimus"

    NDCBrand NameGeneric Name
    0904-7147sirolimussirolimus
    0904-7248SirolimusSirolimus
    13668-658SirolimusSirolimus
    16714-187sirolimussirolimus
    16714-188sirolimussirolimus
    16714-189sirolimussirolimus
    68084-956SirolimusSirolimus
    68084-915SirolimusSirolimus
    68382-520sirolimussirolimus
    70954-075SirolimusSirolimus
    50268-718SirolimusSirolimus
    55111-654SirolimusSirolimus
    55111-653SirolimusSirolimus
    59762-1002SirolimusSirolimus
    59762-1003SirolimusSirolimus
    59762-1001SirolimusSirolimus
    65841-771sirolimussirolimus
    66689-347SirolimusSirolimus
    59762-1205SirolimusSirolimus
    69238-1594SirolimusSirolimus
    60505-6197SirolimusSirolimus
    68462-682sirolimussirolimus
    68462-684sirolimussirolimus
    68462-683sirolimussirolimus
    0008-1030RapamuneSIROLIMUS
    0008-1040RapamuneSIROLIMUS
    0008-1041RapamuneSIROLIMUS
    0008-1042RapamuneSIROLIMUS

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.